Trials
Search / Trial NCT05646108

Tubridge Flow Diverter Study For Intracranial Aneurysms

Launched by MICROPORT NEUROTECH CO., LTD. · Dec 2, 2022

Trial Information

Current as of February 05, 2025

Unknown status

Keywords

Flow Diverter Intracranial Aneurysm Cerebral Aneurysm

ClinConnect Summary

A cerebral aneurysm (also known as an intracranial or intracerebral aneurysm) is a weak or thin spot on a blood vessel in the brain that balloons out and fills and intermixes with parent artery blood. Incidence of intracranial aneurysms varies by country, with reports of prevalence ranging from 5.1 to 19.6 cases per 100,000 persons. The most devastating presentation of an intracranial aneurysm is subarachnoid hemorrhage (SAH). It is estimated that, on average, five percent of the population is afflicted and the incidence of aneurysm rupture (SAH) is between 6 and 9 per 1000 000 individuals ...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. received Tubridge flow diverter treatment for intracranial aneurysm after the date of regulatory approval in China
  • Exclusion Criteria:
  • None

Trial Officials

Jianmin Liu, Ph.D

Study Chair

Changhai Hospital

About Microport Neurotech Co., Ltd.

MicroPort NeuroTech Co., Ltd. is a leading innovator in the development of advanced neurotechnological solutions aimed at enhancing the treatment of neurological disorders. With a commitment to improving patient outcomes through cutting-edge research and development, the company specializes in the design, manufacturing, and commercialization of medical devices that address complex neurological conditions. MicroPort NeuroTech leverages its expertise in neurostimulation, neuromodulation, and neurorehabilitation to drive clinical advancements and foster collaborations within the healthcare community, ultimately striving to enhance the quality of life for patients worldwide.

Locations

Shanghai, , China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials